Skip to main content
. 2011 Oct 12;366(1579):2743–2747. doi: 10.1098/rstb.2011.0040

Figure 5.

Figure 5.

The number of manufacturers and the decline in price of pentavalent (DTP, hepatitis B, Hib) vaccine. Dashed line, expected prequalified manufacturers based in emerging markets; red bars, prequalified manufacturers based in emerging markets; light blue bars, prequalified industrialized country manufacturers; solid red line, weighted average price (WAP).